I-Mab ADR (IMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMAB | LCTX | AUTL | ||
| Company | I-Mab ADR | Lineage Cell Therapeutics Inc | Autolus Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 4.70 | 1.6600 | 1.4400 | ||
| High | 4.77 | 1.7355 | 1.4599 | ||
| Low | 4.49 | 1.6200 | 1.3700 | ||
| Latest | 4.63 | 1.7000 | 1.3800 | ||
| Change | -0.01 | +0.0500 | -0.0600 | ||
| % Change | -0.22% | +3.03% | -4.17% | ||
| Volume | 1,517,300 | 1,470,700 | 1,912,000 | ||
| 20-Day Average Volume | 2,165,250 | 1,247,890 | 2,716,355 | ||
| Previous Close | 4.64 | 1.6500 | 1.4400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.00 | 1.6930 | 1.7130 | ||
| 20-Day Raw Stochastic | 25.00% | 48.08% | 5.48% | ||
| 20-Day Relative Strength | 50.83 | 49.90 | 41.60 | ||
| Weighted Alpha | +111.30 | +137.01 | -37.78 | ||
| Today's Opinion | 80% Buy | 64% Buy | 56% Sell | ||
| Previous Opinion | 80% Buy | 48% Buy | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 72% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.94% since 10/22/25 | -0.58% since 01/09/26 | -23.76% since 01/09/26 | ||
| Low | 4.13 on 10/24/25 | 1.6200 on 01/16/26 | 1.3400 on 01/14/26 | ||
| High | 4.88 on 10/28/25 | 1.7850 on 01/12/26 | 1.7900 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | +35.38% since 09/29/25 | -5.56% since 12/16/25 | -13.75% since 12/16/25 | ||
| Low | 3.46 on 09/30/25 | 1.5750 on 12/30/25 | 1.3400 on 01/14/26 | ||
| High | 6.79 on 10/16/25 | 1.8350 on 01/07/26 | 2.0700 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +172.35% since 07/29/25 | unch since 10/16/25 | -17.86% since 10/16/25 | ||
| Low | 1.75 on 07/30/25 | 1.5300 on 11/07/25 | 1.2000 on 11/21/25 | ||
| High | 6.79 on 10/16/25 | 2.0900 on 11/03/25 | 2.0700 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +470.20% since 04/29/25 | +66.67% since 07/16/25 | -43.44% since 07/16/25 | ||
| Low | 0.81 on 04/30/25 | 0.9296 on 07/22/25 | 1.2000 on 11/21/25 | ||
| High | 6.79 on 10/16/25 | 2.0900 on 11/03/25 | 2.7000 on 07/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 378,086 | 391,558 | 367,277 | ||
| Shares Outstanding, K | 81,660 | 230,328 | 266,143 | ||
| Annual Sales | 0 | 9,500,000 | 10,120,000 | ||
| Annual Net Income | -22,230,000 | -18,610,000 | -220,660,000 | ||
| Last Quarter Sales | 0 | 3,680,000 | 21,190,000 | ||
| Last Quarter Net Income | -5,500,000 | -29,780,000 | -79,120,000 | ||
| 60-Month Beta | 1.45 | 1.74 | 2.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/20/25 | -0.13 on 11/06/25 | -0.30 on 11/12/25 | ||
| Latest Earnings Date | 11/13/25 | 03/09/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||